New Strong Sell Stocks for September 15th

Celanese (CE), Elevance Health (ELV), and ARMOUR Residential REIT (ARR) have been downgraded to Zacks Rank #5 (Strong Sell) following significant downward revisions to their current year earnings estimates. Over the past 60 days, consensus estimates for these companies fell by 14.2%, 13.1%, and 7.1% respectively, indicating a deteriorating fundamental outlook.

Analysis

Three companies across distinct sectors—Celanese (CE) in chemicals, Elevance Health (ELV) in health insurance, and ARMOUR Residential REIT (ARR) in real estate finance—have been downgraded to Zacks Rank #5 (Strong Sell), indicating a significant negative shift in their outlook. The downgrades are underpinned by material, negative revisions to their current-year consensus earnings estimates over the past 60 days. Specifically, Celanese saw its earnings estimate revised downward by 14.2%, Elevance Health by 13.1%, and ARMOUR Residential REIT by 7.1%. Such substantial revisions, particularly the double-digit declines for CE and ELV, signal a marked deterioration in their fundamental earnings power and raise concerns about their near-term financial performance.

Key Decisions for Investors

• Investors with existing long positions in Celanese (CE), Elevance Health (ELV), and ARMOUR Residential REIT (ARR) should critically reassess their holdings due to the heightened risk of underperformance signaled by the 'Strong Sell' ratings and significant downward earnings revisions.
• The substantial negative revisions for CE (14.2%) and ELV (13.1%) make these stocks potential candidates for short-selling or bearish options strategies, as this fundamental weakness may not yet be fully reflected in their stock prices.
• Traders should monitor these tickers for increased volatility and negative price momentum, while fundamental investors should await the next earnings reports to see if management guidance confirms this deteriorating outlook before considering any position.